Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Janning

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Hamostaseologie|October 31, 2013
Relevant bleeding diathesis due to acquired factor XIII deficiencyM Janning, K Holstein, B Spath, et al.
Nature Communications|August 18, 2017
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme BM Wroblewski, R Bauer, M Cubas Córdova, et al.
International Journal of Cancer|January 21, 2016
A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cellsG E Hvichia, Z Parveen, C Wagner, et al.
ESMO Open|November 26, 2025
Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor boardE Krieghoff-Henning, T Michaeli, T Boch, et al.
Leukemia|March 5, 2020
Correction: Role of growth arrest-specific gene 6-mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
Leukemia|August 9, 2014
Role of Growth arrest-specific gene 6-Mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
ESMO Open|July 15, 2025
Treatment outcome of NSCLC patients with BRAF<sup>non-V600E</sup> mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in GermanyC Kropf-Sanchen, A Rasokat, P Christopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2022
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)M Janning, J Süptitz, C Albers-Leischner, et al.
Lung Cancer (Amsterdam, Netherlands)|September 2, 2020
Risk stratification of EGFR<sup>+</sup> lung cancer diagnosed with panel-based next-generation sequencingP Christopoulos, M Kirchner, J Roeper, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Hamostaseologie|October 31, 2013
Relevant bleeding diathesis due to acquired factor XIII deficiencyM Janning, K Holstein, B Spath, et al.
Nature Communications|August 18, 2017
Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme BM Wroblewski, R Bauer, M Cubas Córdova, et al.
International Journal of Cancer|January 21, 2016
A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cellsG E Hvichia, Z Parveen, C Wagner, et al.
ESMO Open|November 26, 2025
Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor boardE Krieghoff-Henning, T Michaeli, T Boch, et al.
Leukemia|March 5, 2020
Correction: Role of growth arrest-specific gene 6-mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
Leukemia|August 9, 2014
Role of Growth arrest-specific gene 6-Mer axis in multiple myelomaJ S Waizenegger, I Ben-Batalla, N Weinhold, et al.
ESMO Open|July 15, 2025
Treatment outcome of NSCLC patients with BRAF<sup>non-V600E</sup> mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in GermanyC Kropf-Sanchen, A Rasokat, P Christopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2022
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)M Janning, J Süptitz, C Albers-Leischner, et al.
Lung Cancer (Amsterdam, Netherlands)|September 2, 2020
Risk stratification of EGFR<sup>+</sup> lung cancer diagnosed with panel-based next-generation sequencingP Christopoulos, M Kirchner, J Roeper, et al.
Pageof 1